Press Releases

Trial Powered by Clinpal a finalist in Eyeforpharma Barcelona Awards for the most valuable patient initiative

Mar 2, 2015, 00:00 AM by Michael Croft
STIRLING, UNITED KINGDOM - Mar 2, 2015 - eClinicalHealth Limited, a technology and consulting company dedicated to providing more efficient cloud-based clinical trial solutions, today announced that one of the trials it is supporting is a finalist to receive Eyefopharma's Most Valuable Patient Initiative award

STIRLING, UNITED KINGDOM - Mar 2, 2015 - eClinicalHealth Limited, a technology and consulting company dedicated to providing more efficient cloud-based clinical trial solutions, today announced that one of the trials it is supporting is a finalist to receive Eyefopharma’s Most Valuable Patient Initiative award.

The first-ever virtual trial to be conducted in Europe, the study is the result of a collaboration between eClinicalHealth, Finnish company Mendor, global healthcare leader Sanofi and others. Called the VERKKO study, it is aimed at examining the effectiveness of the Mendor Smart 3G wireless blood glucose monitor. Thanks in part to cloud-based eClinicalHealth technology, the monitor automatically transmits patients’ blood glucose data so patients and physicians can make real-time decisions about diet and medications.

“This trial is historic not only because it’s Europe’s first remote clinical study to include fully electronic informed consent,” said Kai Langel, Co-Founder and Director, Patient Solutions at eClinicalHealth. “It proves the virtual model saves time and money in patient recruitment and makes everything easier for patients. This simplicity ensures better patient retention and more engaged stakeholders.

”With its nomination, eClinicalHealth joins an elite group of global organizations including Abbott BGP, Allergan, Bayer, CSL Behring, GlaxoSmithKline, Ferring Pharmaceuticals, Sanofi and other major European and global companies.

Participants learn about the study through an electronic patient information sheet, which they can study at home on their own schedules. Before electronically signing electronic informed consent forms, they can ask questions from the Investigator using Clinpal’s messaging features. Once enrolled, study materials are delivered to their home. The Clinpal system then helps them set up the Mendor Smart wireless glucose meter. Once connected, the Mendor Smart device guides patients through a structured glucose profiling protocol, with patients accessing detailed profiling reports in real time through Clinpal.

The VERKKO trial provides a unique and efficient trial experience for the patients, which is also reflected in the judge’s comments: “Every patient’s dream trial!”

While the trial itself is a unique innovation, the partner collaboration is also exceptional thanks to the eClinicalHealth platform’s ability to enhance stakeholder communication. eClinicalHealth provided its Clinpal platform, expertise and leadership in executing the project, Mendor provided its Smart devices and diabetes expertise, Langland created the branding and patient outreach for the study and Sanofi provided funding and clinical expertise.

“VERKKO has been a very rewarding experience for all partners and we’re extremely pleased with the progress and results so far,” said Langel. “Clearly the study has been a great experience for patients - easier and simpler than usual - and the initial results were available more quickly than expected. We enrolled patients faster but beyond that the successful compliance with complex study procedures is proof that this approach can deliver impressive results for investigators and patients.”

The awards ceremony will be on March 24 in Barcelona, Spain as part of the Eyeforpharma Barcelona event. For a list of all finalists and event information, please follow this link: http://www.eyeforpharma.com/barcelona/awards-finalists-2015.php.

 

About eClinicalHealth Headquartered in Scotland, eClinicalHealth Limited developed the revolutionary Clinpal patient engagement platform, which simplifies clinical trial technology, accelerates patient recruiting, enhances stakeholder communication, drives patient engagement and ultimately provides greater efficiency and cost savings. Founded in early 2012 to provide innovative clinical trial solutions, the company is committed to leading open and collaborative innovation discussions about virtual clinical trial processes and technology with pharmaceutical companies, CROs and other service and technology providers.

 

Contact: Kai Langel

Email: klangel@eClinicalHealth.com Office: +44 333 012 4205

Web: www.clinpal.com 

For more information about the collaborating partners visit www.eClinicalHealth.com, www.langland.co.uk, and www.mendor.com